Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPHP
2226
DELISTED
PHP Ventures Acquisition Corp. Class A Common Stock
PPHP
| $166K | ﹤0.01% |
16,000
-16,000
| -50% | -$164K |
|
|
RPT
2227
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $166K | ﹤0.01% |
16,517
-16,519
| -50% | -$163K |
|
|
TE
2228
T1 Energy
TE
$1.19B
| $164K | ﹤0.01% |
18,900
-18,900
| -50% | -$237K |
|
2229
TFS Financial
TFSL
$5.06B
| $164K | ﹤0.01% |
11,373
-11,371
| -50% | -$155K |
|
2230
Fastly Inc
FSLY
$3.37B
| $163K | ﹤0.01% |
19,835
-19,837
| -50% | -$174K |
|
2231
Montauk Renewables
MNTK
$260M
| $162K | ﹤0.01% |
14,688
-14,686
| -50% | -$196K |
|
2232
Novavax
NVAX
$1.22B
| $161K | ﹤0.01% |
15,667
-15,669
| -50% | -$277K |
|
2233
ProPetro Holding
PUMP
$1.33B
| $160K | ﹤0.01% |
15,445
-15,447
| -50% | -$163K |
|
2234
ImmunityBio
IBRX
$7.8B
| $160K | ﹤0.01% |
31,622
-31,622
| -50% | -$174K |
|
2235
Sportsman's Warehouse
SPWH
$45.3M
| $160K | ﹤0.01% |
16,962
-19,780
| -54% | -$182K |
|
2236
Petco
WOOF
$794M
| $159K | ﹤0.01% |
16,840
-16,840
| -50% | -$173K |
|
2237
Clean Energy Fuels
CLNE
$425M
| $158K | ﹤0.01% |
30,332
-30,336
| -50% | -$186K |
|
|
HTBK
2238
DELISTED
Heritage Commerce
HTBK
| $158K | ﹤0.01% |
12,156
-12,156
| -50% | -$164K |
|
|
HAPN
2239
Happen Inc
HAPN
$2.23B
| $158K | ﹤0.01% |
17,922
-17,922
| -50% | -$185K |
|
|
SUMO
2240
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $157K | ﹤0.01% |
19,358
-19,362
| -50% | -$147K |
|
2241
Ecovyst
ECVT
$1.32B
| $156K | ﹤0.01% |
+17,584
| New | +$162K |
|
2242
Fate Therapeutics
FATE
$293M
| $156K | ﹤0.01% |
15,419
-2,834,033
| -99% | -$53.2M |
|
2243
Kearny Financial
KRNY
$606M
| $155K | ﹤0.01% |
15,308
-15,308
| -50% | -$154K |
|
|
INN
2244
Summit Hotel Properties
INN
$748M
| $155K | ﹤0.01% |
21,464
-21,464
| -50% | -$168K |
|
2245
Titan International
TWI
$475M
| $155K | ﹤0.01% |
10,083
-10,081
| -50% | -$144K |
|
|
PLYA
2246
DELISTED
Playa Hotels & Resorts
PLYA
| $154K | ﹤0.01% |
23,644
-23,644
| -50% | -$140K |
|
|
RWT
2247
Redwood Trust
RWT
$585M
| $154K | ﹤0.01% |
22,817
-22,821
| -50% | -$159K |
|
2248
Payoneer
PAYO
$2.42B
| $154K | ﹤0.01% |
28,137
-28,141
| -50% | -$177K |
|
2249
Iovance Biotherapeutics
IOVA
$2.09B
| $154K | ﹤0.01% |
24,044
-24,046
| -50% | -$188K |
|
|
BLUE
2250
DELISTED
bluebird bio
BLUE
| $152K | ﹤0.01% |
+1,097
| New | +$155K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.